Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph M Piepmeier

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Proceedings of the National Academy of Sciences of the United States of America|July 3, 2013
Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastomaJiangbing Zhou, Toral R Patel, Rachael W Sirianni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2007
Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study GroupSandeep Kunwar, Michael D Prados, Susan M Chang, et al.
ACS Nano|March 12, 2016
Increased Nanoparticle Delivery to Brain Tumors by Autocatalytic Priming for Improved Treatment and ImagingLiang Han, Derek K Kong, Ming-Qiang Zheng, et al.
Nature Genetics|August 23, 2016
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomasVictoria E Clark, Akdes Serin Harmancı, Hanwen Bai, et al.
Science (New York, N.Y.)|January 26, 2013
Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMOVictoria E Clark, E Zeynep Erson-Omay, Akdes Serin, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Proceedings of the National Academy of Sciences of the United States of America|July 3, 2013
Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastomaJiangbing Zhou, Toral R Patel, Rachael W Sirianni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2007
Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study GroupSandeep Kunwar, Michael D Prados, Susan M Chang, et al.
ACS Nano|March 12, 2016
Increased Nanoparticle Delivery to Brain Tumors by Autocatalytic Priming for Improved Treatment and ImagingLiang Han, Derek K Kong, Ming-Qiang Zheng, et al.
Nature Genetics|August 23, 2016
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomasVictoria E Clark, Akdes Serin Harmancı, Hanwen Bai, et al.
Science (New York, N.Y.)|January 26, 2013
Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMOVictoria E Clark, E Zeynep Erson-Omay, Akdes Serin, et al.
Pageof 3